You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

 

Online download statistics by month:

Online download statistics by month: October 2021 to January 2026

AbstractFullPdf
Oct 2021704705189
Nov 2021423422143
Dec 202115715974
Jan 202210811753
Feb 202213414575
Mar 202214614963
Apr 202223923976
May 202211111246
Jun 202212812845
Jul 202212913340
Aug 202213013047
Sep 202213415058
Oct 202214914946
Nov 202213413457
Dec 202210310343
Jan 202310811162
Feb 202315015040
Mar 202311311651
Apr 2023979742
May 202310310646
Jun 2023919433
Jul 2023879439
Aug 2023959537
Sep 202311011133
Oct 202310310347
Nov 202312312525
Dec 202314314335
Jan 202410310430
Feb 202414914947
Mar 202413513640
Apr 202414915042
May 202414114248
Jun 202411911829
Jul 202415615746
Aug 202420620539
Sep 202417617742
Oct 2024929243
Nov 2024939438
Dec 202413313849
Jan 202510610642
Feb 202512812856
Mar 202511011040
Apr 202511912049
May 202512012134
Jun 2025737337
Jul 2025110
Sep 2025110
Jan 2026110
Total656366432296